Related references
Note: Only part of the references are listed.Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma
Chen Liang et al.
MOLECULAR CANCER RESEARCH (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
A novel monoclonal antibody to a defined peptide epitope in MUC16
Lara Marcos-Silva et al.
GLYCOBIOLOGY (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Characterization of Binding Epitopes of CA125 Monoclonal Antibodies
Lara Marcos-Silva et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Prakash Radhakrishnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
Stefan Eser et al.
CANCER CELL (2013)
Targeting the NF-κB and mTOR Pathways with a Quinoxaline Urea Analog That Inhibits IKKβ for Pancreas Cancer Therapy
Prakash Radhakrishnan et al.
CLINICAL CANCER RESEARCH (2013)
Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer
Neeley Remmers et al.
CLINICAL CANCER RESEARCH (2013)
Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology
Catharina Steentoft et al.
EMBO JOURNAL (2013)
Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis
Prakash Radhakrishnan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
Shih-Hsun Chen et al.
SCIENTIFIC REPORTS (2013)
Site-specific protein O-glycosylation modulates proprotein processing - Deciphering specific functions of the large polypeptide GalNAc-transferase gene family
Katrine T. -B. G. Schjoldager et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Sialyl-Tn in Cancer: (How) Did We Miss the Target?
Sylvain Julien et al.
BIOMOLECULES (2012)
Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines
Catharina Steentoft et al.
NATURE METHODS (2011)
Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
Dhanya Haridas et al.
PLOS ONE (2011)
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Ola Soderberg et al.
NATURE METHODS (2006)
RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells
Hideaki Tsutsumida et al.
CLINICAL CANCER RESEARCH (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
MG Schlieman et al.
BRITISH JOURNAL OF CANCER (2003)
Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas
GE Kim et al.
GASTROENTEROLOGY (2002)
The CA 125 gene: An extracellular superstructure dominated by repeat sequences
TJ O'Brien et al.
TUMOR BIOLOGY (2001)
Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13 - Evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo
AA Noujaim et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Share Paper
